title: Homozygous deletions within human chromosome band 9p21 in melanoma.
abstract: Genetic studies have implicated the early involvement of a gene on chromosome arm 9p in the development of cutaneous melanoma. We have performed loss-of-heterozygosity studies to confirm these original findings and identify the most frequently rearranged or deleted region of 9p. Eight markers were analyzed, including (from 9pter to proximal 9q) D9S33, the beta-interferon (IFNB1) locus, the alpha-interferon (IFNA) gene cluster, D9S126, D9S3, D9S19, the glycoprotein 4 beta-galactosyltransferase (GGTB2) gene, and the argininosuccinate synthetase pseudogene 3 (ASSP3). Two or more of these loci were found to be hemizygously reduced in 12 of 14 (86%) informative metastatic melanoma tumor and cell line DNAs, and homozygous deletions of the marker D9S126 were observed in 2 of 20 (10%) melanoma cell lines. These findings have resulted in the identification of a small critical region of 2-3 megabases on 9p21 in which a putative melanoma tumor-suppressor gene appears likely to reside. Several 9p candidate genes, including IFNB1, the IFNA gene cluster, GGTB2, and the tyrosinase-related protein (TYRP) locus, have all been eliminated as potential targets because they are located outside of the homozygously deleted regions.
authors.affiliation: Center for Cancer Research, Massachusetts Institute of Technology, Cambridge 02139.
authors.forename: J W
authors.initials: JW
authors.lastname: Fountain
authors.forename: M
authors.initials: M
authors.lastname: Karayiorgou
authors.forename: M S
authors.initials: MS
authors.lastname: Ernstoff
authors.forename: J M
authors.initials: JM
authors.lastname: Kirkwood
authors.forename: D R
authors.initials: DR
authors.lastname: Vlock
authors.forename: L
authors.initials: L
authors.lastname: Titus-Ernstoff
authors.forename: B
authors.initials: B
authors.lastname: Bouchard
authors.forename: S
authors.initials: S
authors.lastname: Vijayasaradhi
authors.forename: A N
authors.initials: AN
authors.lastname: Houghton
authors.forename: J
authors.initials: J
authors.lastname: Lahti
mesh_terms: D001483:Base Sequence; D002460:Cell Line; D002871:Chromosome Banding; D002872:Chromosome Deletion; D002899:Chromosomes, Human, Pair 9; D004273:DNA, Neoplasm / Q000235:genetics / Q000302:isolation & purification; D005819:Genetic Markers; D006720:Homozygote; D006801:Humans; D016898:Interferon-alpha / Q000235:genetics; D016899:Interferon-beta / Q000235:genetics; D008545:Melanoma / Q000235:genetics* / Q000601:surgery; D008562:Membrane Glycoproteins; D008969:Molecular Sequence Data; D005810:Multigene Family; D009838:Oligodeoxyribonucleotides; D010088:Oxidoreductases; D016133:Polymerase Chain Reaction / Q000379:methods; D011506:Proteins / Q000235:genetics; D006022:beta-N-Acetylglucosaminylglycopeptide beta-1,4-Galactosyltransferase / Q000235:genetics
chemical_list: D004273:DNA, Neoplasm; D005819:Genetic Markers; D016898:Interferon-alpha; D008562:Membrane Glycoproteins; D009838:Oligodeoxyribonucleotides; D011506:Proteins; D016899:Interferon-beta; D010088:Oxidoreductases; C489799:TYRP1 protein, human; C064056:tyrosinase-related protein-1; D006022:beta-N-Acetylglucosaminylglycopeptide beta-1,4-Galactosyltransferase